Nefiracetam elevates extracellular acetylcholine level in the frontal cortex of rats with cerebral cholinergic dysfunctions: An in vivo microdialysis study

Neuroscience Letters

Volumn 246, Issue 2, 1998, Pages 69-72

  Sakurai, Takeo ^a,c   Kato, Takeshi ^b   Mori, Kumiko ^a   Takano, Emi ^a   Watabe, Shigeo ^a   Nabeshima, Toshitaka ^c  

^a DAIICHI SANKYO CO   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acetylcholine; Cholinergic dysfunction; Frontal cortex; Microdialysis; Nefiracetam; Rat

Indexed keywords

NEFIRACETAM;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; LEARNING; LEARNING DISORDER; MICRODIALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0032562553     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00244-4     Document Type: Article

References (21)

1. Giovannini, M.G., Radinò, P., Mutolo, D. and Pepeu, G., Oxiracetam and aniracetam increase acetylcholine release from the rat hippocampus in vivo, Drug Dev. Res., 28 (1993) 503-509.
2. Kato, T., Liu, J.K., Yamamoto, K., Osborne, P.G. and Niwa, O., Detection of basal acetylcholine release in the microdialysis of rat frontal cortex by high-performance liquid chromatography using a horseradish peroxidase-osmium redox polymer electrode with pre-enzyme reactor, J. Chromatogr. B., 682 (1996) 162-166.
3. Kawajiri, S., Taniguchi, K., Sakurai, T. and Yamasaki, T., Nefiracetam enhances acetylcholine outflow from the frontal cortex: in vivo microdialysis study in the rat, J. Neural. Transm., 98 (1994) 15-22.
4. Kawashima, K., Sato, A., Yoshizawa, M., Fujii, T., Fujimoto, K. and Suzuki, T., Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 350 (1994) 523-528.
5. Kojima, H., Kawajiri, S., Sakurai, T. and Yamasaki, T., Effect of DM-9384, a new pyrrolidone derivative, on passive avoidance and cerebral choline acetyltransferase activity in rats. In T. Nagatsu and M. Yoshida (Eds.), Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, Vol. 2, Plenum Press, New York, 1990, pp. 367-370.
6. Liu, J.K. and Kato, T., Effect of physostigmine on relative acetyl choline output induced by systemic treatment with scopolamine in in vivo microdialysis of rat frontal cortex, Neurochem. Int., 24 (1994) 589-596.
7. Messamore, E., Warpman, U., Williams, E. and Giacobini, E., Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition, Neurosci. Lett., 158 (1993) 205-208.
8. Miller, R.J., Calcium signalling in neurons, Trends Neurosci., 11 (1988) 415-419.
9. Nabeshima, T., Ogawa, S., Kameyama, T., Shiotani, T., Takasu, Y., Sakurai, T., Hasegawa, M. and Hasegawa, T., Effects of DM-9384 and aniracetam on learning in normal and basal forebrain-lesioned rats, Res. Commun. Chem. Psychol. Psychiatr. Behav., 16 (1991) 1-14.
10. A and muscarinic receptors induced by cycloheximide, J. Pharmacol. Exp. Ther., 257 (1991) 271-275.
11. Nabeshima, T., Ameliorating effects of nefiracetam (DM-9384) on brain dysfunction, Drugs Today, 30 (1994) 357-379.
12. Ogura, H., Kosasa, T., Araki, S., Yamanishi, Y. and Yamatsu, K., Behavioral study of E-2020, a novel centrally acting acetylcholinesterase inhibitor, Soc. Neurosci. Abstr., 14 (1988) 60.
13. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1982.
14. Pugsley, T.A., Shin, Y.-H., Coughenour, L. and Stewart, S.F., Some neurochemical properties of pramiracetam (CI-879), a new cognition enhancing agent, Drug Dev. Res., 3 (1983) 407-420.
15. Sakurai, T., Ojima, H., Yamasaki, T., Kojima, H. and Akashi, A., Effects of N-(2.6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide (DM-9384) on learning and memory in rats, Jpn. J. Pharmacol., 50 (1989) 47-53.
16. Tobe, A., Yamaguchi, T., Nagai, R. and Egawa, M., Effects of bifemelane hydrochloride (MCI-2016) on experimental amnesia (passive avoidance failure) in rodents, Jpn. J. Pharmacol., 39 (1985) 153-161.
17. Toide, K. and Arima, T., Effects of cholinergic drugs on extra-cellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis, Eur. J. Pharmacol., 173 (1989) 133-141.
18. Vannucchi, M.G. and Pepeu, G., Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus, Neurosci. Lett., 190 (1995) 53-56.
19. Watabe, S., Yamaguchi, H. and Ashida, S., Effects of DM-9384, a new cognition-enhancing agent, on cholinergic system in rat cortex, Soc. Neurosci. Abstr., 16 (1990) 137.
20. 2 receptor antagonist, BIBN 99, on acetylcholine release in aged rats and spatial memory performance in scopolamine treated rats, Soc. Neurosci. Abstr., 19 (1993) 1813.
21. Yoshii, M. and Watabe, S., Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells, Brain Res., 642 (1994) 123-131.